These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2237186)

  • 1. [Iatrogenic lupus].
    Hatron PY
    Rev Prat; 1990 Sep; 40(21):1941-3. PubMed ID: 2237186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleritis as the presenting manifestation of procainamide-induced lupus.
    Turgeon PW; Slamovits TL
    Ophthalmology; 1989 Jan; 96(1):68-71. PubMed ID: 2645552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute acalculous cholecystitis and cardiac tamponade in a patient with drug-induced lupus.
    Rozin A; Lorber M; Ben-Ami H; Reisner S; Kaftori JK; Edoute Y
    Rheumatology (Oxford); 2001 Jun; 40(6):709-11. PubMed ID: 11426036
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesalazine-induced lupus.
    Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
    Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-related lupus.
    Hess EV
    Curr Opin Rheumatol; 1991 Oct; 3(5):809-14. PubMed ID: 1751313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced antinuclear antibodies and lupus syndromes.
    Alarcón-Segovia D
    Drugs; 1976; 12(1):69-77. PubMed ID: 789044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus erythematosus. 2. Systemic Lupus erythematosus: antibody symptomatology, other laboratory evidence, diagnosis, course and prognosis; discoid Lupus erythematosus; drug induced Lupus].
    Frojo M; Lamparelli A; Palomba F; Rullo R
    Arch Stomatol (Napoli); 1989 Oct; 30(4):901-35. PubMed ID: 2701639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa].
    Homberg JC; Abuaf N; Plouin PF; Ménard J; Fillastre JP
    J Pharmacol; 1983; 14 Suppl 2():61-6. PubMed ID: 6138472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of autoreactive T cell drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus.
    Kretz-Rommel A; Rubin RL
    J Immunol; 1999 Jan; 162(2):813-20. PubMed ID: 9916703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus disease with antinuclear antibodies of the nucleolar type. Apropos of a series of 13 cases].
    Meyer O; Bourgeois P; Zakraoui L; Piette JC; Ziza JM; Blétry O; Kahn MF; Godeau P; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):1-6. PubMed ID: 3281241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.
    Mongey AB; Sim E; Risch A; Hess E
    J Rheumatol; 1999 Aug; 26(8):1721-6. PubMed ID: 10451068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice.
    Cohen MG; Pollard KM; Schrieber L
    Clin Exp Immunol; 1988 Apr; 72(1):50-4. PubMed ID: 3260838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lupus-related specific autoantibodies by non-specific inflammation caused by an intraperitoneal injection of n-hexadecane in BALB/c mice.
    Kuroda Y; Ono N; Akaogi J; Nacionales DC; Yamasaki Y; Barker TT; Reeves WH; Satoh M
    Toxicology; 2006 Feb; 218(2-3):186-96. PubMed ID: 16309812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe retinal vaso-occlusive disease secondary to procainamide-induced lupus.
    Nichols CJ; Mieler WF
    Ophthalmology; 1989 Oct; 96(10):1535-40. PubMed ID: 2587049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
    Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
    Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-U1RNP antibodies and lupus nephritis].
    Ilić T; Curić S; Vodopivec S; Mitić I; Durdević-Mirković T; Sakac V; Lenert P
    Med Pregl; 2000; 53(11-12):589-94. PubMed ID: 11320745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity against nucleosomes and lupus nephritis.
    Van Bruggen MC; Kramers C; Berden JH
    Ann Med Interne (Paris); 1996; 147(7):485-9. PubMed ID: 9092359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.
    Jallouli M; Frigui M; Hmida MB; Marzouk S; Kaddour N; Bahloul Z
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carpal tunnel syndrome. First manifestation of systemic lupus erythematosus.
    Sidiq M; Kirsner AB; Sheon RP
    JAMA; 1972 Dec; 222(11):1416-7. PubMed ID: 4117886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.